London, United Kingdom, February 25, 2016 --(PR.com
)-- The two day conference will explore novel and emerging non-clinical ADME approaches, structure based prediction of ADME properties, PK/PD modelling to validate drug targets, toxicity and much more.
Day 1 will address topics on optimisation for drug design and discovery as well as translating non-clinical ADME data to the clinic while Day 2 explores linking PK with safety and improving drug-drug interaction.
Key Presentations Not To Be Missed:
Carl Petersson, DMPK NCE Senior Designer from Merck Serono will present on Day One of the event with his presentation entitled ‘Early dose predictions – a valuable tool in risk assessment and optimisation of small molecules’ The session will focus on the value of integrating translational PKPD in early development as well as the requirements for translational PKPD.
On Day Two of the event Friedemann Schmidt, R&D DSAR Preclinical Safety, Sanofi-Aventis will discuss: current preclinical in silico toxicology; ADMET modelling, leading to quantitative structure-toxicity relationships as well as analysing and predicting pre-/clinical toxicity based on target interaction profiles.
Joining Merck Serono and Sanofi-Aventis at ADMET 2016 will include senior industry thought leaders from University of Surrey, Roche, GSK, UCB Pharma, Genentech, Lundbeck and many more
For the full agenda break down with all speakers and their topics please visit the event website www.admet-event.com/prcom
Highlights for 2016:
• Discover application of PBPK to drug development in rare diseases
• Review the role of drug transporters in drug delivery to CNS diseases
• Learn about better models for understanding, predicting and avoiding drug induced liver injury
• Discuss in silico approaches to evidence-based mechanistic modelling
• Analyse early dose predictions – a valuable tool in risk assessment and optimisation of small molecules
Delegates also have the opportunity to take part in a half-day post-conference workshop. The workshop entitled ‘Molecular properties and intermolecular interactions in virtual ADMET assessment’ will be led by Mire Zloh, Head of Medicinal and Analytical Chemistry Research Group, University of Hertfordshire and Teresa Barata, Research Associate, UCL School of Pharmacy
To register or for further information on the workshop/leaders please visit the event website www.admet-event.com/prcom
For those interested in attending, there is currently an early bird offer available saving £400 off of the conference price which expires on the 29th of February.
ADMET 2016 is sponsored by Corning and Sekisui XenoTech.
For sponsorship enquiries, contact Alia Malick on +44 (0) 207 827 6168 or firstname.lastname@example.org
For delegate enquiries, contact Matthew Apps on +44 (0) 207 827 6093 or email@example.com
For media enquiries, contact Zoe Gale on +44 (0) 207 827 6132 or firstname.lastname@example.org
11th annual ADMET conference and exhibition
13-14 June 2016
Contact e-mail: email@example.com
Contact tel: +44 (0) 207 827 6093
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk